-
International Journal of Wine Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Does wine prevent dementia?
Review
(7629) Views (1436) Full article downloads
Authors: Roger M Pinder
Published Date February 2009
Volume 2009:1 Pages 41 - 52
DOI: http://dx.doi.org/10.2147/IJWR.S4691
Roger M Pinder
Pharma Consultant, York, UK
Abstract: There is substantial evidence that moderate consumption of alcohol reduces significantly the risks of coronary heart disease, stroke and type 2 diabetes. Furthermore, the incidence of dementia, both of the Alzheimer’s type (AD) and the vascular variety (VaD), is lower in societies which consume a Mediterranean diet of mainly fish, fruit, vegetables, olive oil, and wine. In particular, extensive evidence from both population-based cohort and case control studies in different areas of the world and across genders and racial groups suggests that regular consumption of moderate amounts of alcohol, especially in the form of wine, is associated with a lower risk of developing AD and VaD compared with abstention and heavy drinking. Carriers of the APOE ε4 allele seem to gain less benefit. Age-related cognitive decline, particularly in women, is lower in regular drinkers, while older drinkers with Mild Cognitive Impairment (MCI) progress less frequently to AD than their abstaining counterparts. Plausible biological mechanisms for the neuroprotective effects of wine include its glucose-modifying, antioxidant and inflammatory properties, but it additionally seems to modify the neuropathology of AD, particularly the deposition of amyloid plaque. Indeed, some of these mechanisms are already targets for the development of new therapeutic agents for the treatment of dementia.
Keywords: alcohol, Alzheimer’s disease, dementia, epidemiology, polyphenols, wine
Other articles by Dr Roger Pinder
Biodiversity of wine grapes: less than we thought
Editorial Foreword: International Journal of Wine Research
More on the benefits of wine for cognitive decline and dementia
Resveratrol comes of age
Readers of this article also read:
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
Dashboards in neonatology
Resveratrol comes of age
Effects of red wine flavonoid components on biomembranes and cell proliferation
Alcohol-attributable cancer: fact or fiction?
Biodiversity of wine grapes: less than we thought
More on the benefits of wine for cognitive decline and dementia
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Does wine prevent dementia?
- Wine consumers’ environmental knowledge and attitudes: Influence on willingness to purchase
- China’s role in global competition in the wine industry: A new contestant and future trends
- Mycoflora and production of wine from fruits of soursop (Annona Muricata L.)




